Edwards Lifesciences to Market Heart Laser
- Share via
An estimated 6.3 million Americans suffer from angina--a condition in which the heart fails to receive a sufficient amount of blood, sometimes causing severe pain. And 350,000 new cases occur each year, according to the American Heart Assn.
Now, a heart laser made by PLC Medical Systems Inc. of Franklin, Mass., may reduce pain significantly for angina patients by creating tiny holes on the heart’s surface, improving blood flow. Edwards Lifesciences Corp. in Irvine has signed a deal with PLC to distribute and market the carbon-dioxide TMR heart laser, which received market clearance from the Food and Drug Administration.
“This could help the quality of life for thousands and thousands of people,” Edwards Chief Executive Mike Mussallem said.
As part of the distribution pact, Edwards made a $4-million equity investment in PLC. The deal reflects Edwards’ strategy of snapping up or licensing new technologies through partnerships and acquisitions, JP Morgan H&Q; analyst Michael Weinstein said.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.